Clinical Trials Browser

Chondrosarcoma, Clear Cell, Chondrosarcoma, Chondrosarcoma, Mesenchymal

NCT00496522 2026-03-09

Proton Beam Therapy for Chondrosarcoma

Phase 2 Active not recruiting

15 enrolled

Sarcoma

Chondrosarcoma

NCT03442465 2026-03-04

Assessment of Healing and Function After Reconstruction Surgery for Bone Sarcomas

Recruiting

300 enrolled

Sarcoma

Bone Neoplasms, Chondrosarcoma, Sarcoma, Ewing, Osteosarcoma

NCT04091295 2026-03-04

BLESSED: Expanded Access for DNG64-CAR-V for Advanced Pancreatic Cancer, Sarcoma and Carcinoma of Breast

Available

BreastGastrointestinalGenitourinaryGynecologicSarcomaThoracic

Breast Neoplasms, Carcinoma, Non-Small-Cell Lung, Chondrosarcoma, Chordoma, Ovarian Neoplasms, Pancreatic Neoplasms, Prostatic Neoplasms, Sarcoma, Osteosarcoma, Neurofibrosarcoma

NCT04055220 2026-02-17

REGOSTA

Phase NA Recruiting

168 enrolled

Sarcoma

Pathologic Complete Response, Bone Neoplasms, Chondrosarcoma, Hemangiosarcoma, Leiomyosarcoma, Patient Compliance, Sarcoma, Ewing, Osteosarcoma, Histiocytoma, Malignant Fibrous

NCT06387485 2026-02-06

A Study to Evaluate the Utilization of 3D Printed Models in Pre-Operative Planning

Phase NA Recruiting

150 enrolled

Sarcoma

Chondrosarcoma, Fibrosarcoma, Sarcoma, Ewing, Osteosarcoma, Histiocytoma, Benign Fibrous

NCT05779670 2026-02-03

ADER

Recruiting

50 enrolled

Sarcoma

Bone Neoplasms, Chondrosarcoma, Sarcoma, Ewing, Osteosarcoma

NCT05861245 2026-01-23

Hypofractionated Protontherapy in Chordomas and Chondrosarcomas of the Skull Base

Phase NA Recruiting

20 enrolled

Sarcoma

Chondrosarcoma, Chordoma

NCT07360964 2026-01-22

CIRCLE

Phase NA Active not recruiting

77 enrolled

Sarcoma

Chondrosarcoma, Clear Cell, Chondrosarcoma

NCT07315542 2026-01-05

Diagnostic and Therapeutic Targets in Cartilaginous Tumours

Recruiting

300 enrolled

Sarcoma

Chondrosarcoma

NCT06645808 2025-12-29

VARTUTRACE

Phase EARLY_PHASE1 Recruiting

32 enrolled

BreastCNSGastrointestinalGenitourinaryHead & NeckSarcomaThoracic

Squamous Cell Carcinoma of Head and Neck, Urinary Bladder Neoplasms, Breast Neoplasms, Chondrosarcoma, Colonic Neoplasms, Esophageal Neoplasms, Glioblastoma, Lung Neoplasms, Neoplasms, Pancreatic Neoplasms, Rectal Neoplasms, Sarcoma, Osteosarcoma, Stomach Neoplasms

NCT01449149 2025-12-05

Proton Radiation for Chordomas and Chondrosarcomas

Phase NA Completed

54 enrolled 11 charts

Sarcoma

Chondrosarcoma, Chordoma

NCT04278781 2025-10-23

AG-120 in People With IDH1 Mutant Chondrosarcoma

Phase 2 Active not recruiting

6 enrolled

LymphoidSarcoma

Chondrosarcoma, Lymphoma, Follicular

NCT06176989 2025-10-20

Enasidenib in IDH2-Mutated Malignant Sinonasal and Skull Base Tumors

Phase 2 Recruiting

40 enrolled

CNSSarcoma

Sinonasal undifferentiated carcinoma, Chondrosarcoma, Esthesioneuroblastoma, Olfactory

NCT05039801 2025-10-14

IACS-6274 With or Without Bevacizumab and Paclitaxel for the Treatment of Advanced Solid Tumors

Phase 1 Recruiting

54 enrolled

DermatologicGynecologicHead & NeckSarcoma

Squamous Cell Carcinoma of Head and Neck, Chondrosarcoma, Melanoma, Ovarian Neoplasms, Endometrial Neoplasms

NCT02389244 2025-09-16

REGOBONE

Phase 2 Active not recruiting

163 enrolled

Sarcoma

Chondroma, Chondrosarcoma, Osteosarcoma

NCT06535997 2025-08-06

PRIMHADRON

Completed

62 enrolled

LymphoidSarcoma

Chondrosarcoma, Chordoma, Carcinoma, Adenoid Cystic, Hemangiosarcoma, Lymphoma, Follicular, Neoplasms, Sarcoma, Osteosarcoma

NCT04040205 2025-07-20

Abemaciclib for Bone and Soft Tissue Sarcoma With Cyclin-Dependent Kinase (CDK) Pathway Alteration

Phase 2 Recruiting

44 enrolled

Other solid neoplasmSarcoma

Chondrosarcoma, Retinoblastoma, Sarcoma, Osteosarcoma

NCT04087902 2025-07-03

Long-Term Longitudinal QoL in Patients Undergoing EEA

Recruiting

400 enrolled

CNSEndocrineSarcoma

Chondrosarcoma, Chordoma, Craniopharyngioma, Encephalocele, Meningioma, Pituitary Neoplasms, Esthesioneuroblastoma, Olfactory, Central Nervous System Cysts

NCT04521686 2025-06-27

Study of LY3410738 Administered to Patients With Advanced Solid Tumors With IDH1 or IDH2 Mutations

Phase 1 Active not recruiting

200 enrolled

BreastCNSDermatologicGastrointestinalGenitourinaryHead & NeckSarcoma

Breast Neoplasms, Chondrosarcoma, Colonic Neoplasms, Glioblastoma, Glioma, Melanoma, Prostatic Neoplasms, Thyroid Neoplasms, Central Nervous System Neoplasms, Cholangiocarcinoma

NCT04553692 2025-03-28

Phase 1a/1b Study of Aplitabart (IGM-8444) Alone or in Combination in Participants with Relapsed, Refractory, or Newly Diagnosed Cancers

Phase 1 Terminated

272 enrolled

GastrointestinalLymphoidOther hematologic neoplasmSarcoma

Chondrosarcoma, Lymphoma, Non-Hodgkin, Neoplasm Metastasis, Sarcoma, Colorectal Neoplasms, Leukemia, Lymphocytic, Chronic, B-Cell, Leukemia, Myeloid, Acute

Clinical Trials

Vismodegib in Treating Patients With Advanced Chondrosarcomas

Proton Beam Therapy for Chondrosarcoma

Assessment of Healing and Function After Reconstruction Surgery for Bone Sarcomas

BLESSED: Expanded Access for DNG64-CAR-V for Advanced Pancreatic Cancer, Sarcoma and Carcinoma of Breast

REGOSTA

A Study to Evaluate the Utilization of 3D Printed Models in Pre-Operative Planning

ADER

Hypofractionated Protontherapy in Chordomas and Chondrosarcomas of the Skull Base

CIRCLE

Diagnostic and Therapeutic Targets in Cartilaginous Tumours

VARTUTRACE

Proton Radiation for Chordomas and Chondrosarcomas

AG-120 in People With IDH1 Mutant Chondrosarcoma

Enasidenib in IDH2-Mutated Malignant Sinonasal and Skull Base Tumors

IACS-6274 With or Without Bevacizumab and Paclitaxel for the Treatment of Advanced Solid Tumors

REGOBONE

PRIMHADRON

Abemaciclib for Bone and Soft Tissue Sarcoma With Cyclin-Dependent Kinase (CDK) Pathway Alteration

Long-Term Longitudinal QoL in Patients Undergoing EEA

Study of LY3410738 Administered to Patients With Advanced Solid Tumors With IDH1 or IDH2 Mutations

Phase 1a/1b Study of Aplitabart (IGM-8444) Alone or in Combination in Participants with Relapsed, Refractory, or Newly Diagnosed Cancers